VivoSim Labs, Inc. Proceeds from Issuance of Private Placement
VivoSim Labs, Inc. (VIVS) reported Proceeds from Issuance of Private Placement of $8.72 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2013-08-09
- VivoSim Labs, Inc. proceeds from issuance of private placement for the quarter ending 2012-09-30 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month |
|---|---|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $8.72M 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $8.72M 10-Q · filed 2012-08-14 | |||
| 2012-03-16 | $6.90M 10-Q · filed 2013-08-09 | |||
| 2012-02-29 | $1.80M 10-Q · filed 2013-08-09 | |||
| 2012-02-08 | $5.00M 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |